Publication: Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?
Loading...
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
AlphaMed Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Dagogo-Jack, Ibiayi, and Alice T. Shaw. 2016. “Screening for ALK Rearrangements in Lung Cancer: Time for a New Generation of Diagnostics?” The Oncologist 21 (6): 662-663. doi:10.1634/theoncologist.2016-0179. http://dx.doi.org/10.1634/theoncologist.2016-0179.
Abstract
A study reported in this issue of The Oncologist examined the utility of next-generation sequencing (NGS) in detecting ALK rearrangements. NGS may one day become the standard initial test for molecular genotyping of patients with advanced cancers, and this new generation of ALK diagnostics is a welcome addition to the current screening repertoire.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service